About
Small Molecules
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
8
As Collaborator
1
Total Enrollment
331
By Phase
PHASE2: 6PHASE1: 3
By Status
COMPLETED: 6WITHDRAWN: 2UNKNOWN: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
Hover over trial bars to see details
Recent Trials
NCT05198362Lead Sponsor
Study of Tesomet With Open-label Extension in Subjects With Prader-Willi Syndrome
PHASE2Withdrawn
Started: Dec 28, 2021 · Completed: Dec 9, 2022
NCT05147415Lead Sponsor
Study of Tesomet With Open-label Extension in Subjects With Hypothalamic Obesity (HO)
PHASE2Withdrawn
Started: Nov 11, 2021 · Completed: Dec 9, 2022
NCT04971135Lead Sponsor
First-in-human Study of SAN711 in Healthy Participants
PHASE1Unknown
80 participants
Started: Jun 30, 2021 · Completed: Jun 30, 2022
NCT03845075Lead Sponsor
48 Weeks, Study to Evaluate Overall Safety and Tolerability of Co-administration of Tesofensine and Metoprolol in Subjects With Hypothalamic Injury-induced Obesity (HIO)
PHASE2Completed
21 participants
Started: Feb 25, 2019 · Completed: Oct 16, 2020
NCT03488719Lead Sponsor
A Study to Examine the Effect of Tesofensine and Metoprolol on the 24-hour Mean Heart Rate
PHASE1Completed
37 participants
Started: Jul 11, 2018 · Completed: Jun 6, 2019
Locations (1)
Headquarters
Glostrup, Denmark
Map
Loading map...